Because the\u00a0COVID-19\u00a0pandemic is negatively affecting the overall volume of diagnostic imaging procedures, the pandemic will\u00a0have a significant impact on the European contrast agent\u00a0and radiopharmaceutical\u00a0market in the short term. Once the situation improves, the European contrast agent and radiopharmaceutical market will resume\u00a0slow growth\u00a0through 2029, driven by\u00a0rising\u00a0radiopharmaceutical\u00a0ASPs and increasing demand for diagnostic imaging procedures for Europe’s aging population, although the market will be hindered to some extent by stringent reimbursement regulations and the ongoing safety controversy surrounding\u00a0GBCAs.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386290","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-contrast-agents-and-radiopharmaceuticals","medtech-geography-europe","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386290\/revisions"}],"predecessor-version":[{"id":387800,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386290\/revisions\/387800"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}